Coca-Cola is best known for its eponymous caffeine-based drink, but the firm now appears to be experimenting with a different drug: cannabis. The drinks giant is in talks with local producer Aurora Cannabis about developing marijuana-infused beverages. These would not aim to intoxicate consumers but to relieve pain. The firm declined to comment but said it was watching the cannabis drinks market closely. Cannabidiol, a constituent of cannabis, can help ease inflammation, pain and cramping, but has no psychoactive effect.Quoting unnamed sources, BNN Bloomberg said Coca-Cola was in "serious talks" with Aurora but no deal had been finalised. "They're pretty advanced down the path" of doing a deal, one source was quoted as saying. "It's going to be more of the 'recovery drink' category," the source added.